Literature DB >> 25961395

Underestimation of the True Specificity of the Urine Lipoarabinomannan Point-of-Care Diagnostic Assay for HIV-Associated Tuberculosis.

Stephen D Lawn1, Andrew D Kerkhoff, Mark P Nicol, Graeme Meintjes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25961395      PMCID： PMC4486367          DOI： 10.1097/QAI.0000000000000672

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  14 in total

1.  Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres.

Authors:  Taye T Balcha; Niclas Winqvist; Erik Sturegård; Sten Skogmar; Anton Reepalu; Zelalem H Jemal; Gudeta Tibesso; Thomas Schön; Per Björkman
Journal:  Trop Med Int Health       Date:  2014-03-29       Impact factor: 2.622

Review 2.  Towards a point-of-care test for active tuberculosis: obstacles and opportunities.

Authors:  Ruth McNerney; Peter Daley
Journal:  Nat Rev Microbiol       Date:  2011-03       Impact factor: 60.633

3.  Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.

Authors:  Jonathan G Peter; Grant Theron; Richard van Zyl-Smit; Asheen Haripersad; Lynelle Mottay; Sarah Kraus; Anke Binder; Richard Meldau; Anneli Hardy; Keertan Dheda
Journal:  Eur Respir J       Date:  2012-02-23       Impact factor: 16.671

4.  Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.

Authors:  Maunank Shah; Willy Ssengooba; Derek Armstrong; Lydia Nakiyingi; Molly Holshouser; Jerrold J Ellner; Moses Joloba; Yukari C Manabe; Susan E Dorman
Journal:  AIDS       Date:  2014-06-01       Impact factor: 4.177

5.  Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.

Authors:  Lydia Nakiyingi; Vineshree Mischka Moodley; Yukari C Manabe; Mark P Nicol; Molly Holshouser; Derek T Armstrong; Widaad Zemanay; Welile Sikhondze; Olive Mbabazi; Bareng A S Nonyane; Maunank Shah; Moses L Joloba; David Alland; Jerrold J Ellner; Susan E Dorman
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

6.  Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.

Authors:  Stephen D Lawn; Andrew D Kerkhoff; Monica Vogt; Robin Wood
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

7.  Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis.

Authors:  Paul K Drain; Elena Losina; Sharon M Coleman; Janet Giddy; Douglas Ross; Jeffrey N Katz; Ingrid V Bassett
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

8.  Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.

Authors:  Stephen D Lawn; David J Edwards; Katharina Kranzer; Monica Vogt; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

Review 9.  Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.

Authors:  Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2012-04-26       Impact factor: 3.090

Review 10.  Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis.

Authors:  Stephen D Lawn; Robin Wood
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226
View more
  17 in total

Review 1.  Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.

Authors:  Maunank Shah; Colleen Hanrahan; Zhuo Yu Wang; Nandini Dendukuri; Stephen D Lawn; Claudia M Denkinger; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2016-05-10

Review 2.  Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV.

Authors:  Stephanie Bjerrum; Ian Schiller; Nandini Dendukuri; Mikashmi Kohli; Ruvandhi R Nathavitharana; Alice A Zwerling; Claudia M Denkinger; Karen R Steingart; Maunank Shah
Journal:  Cochrane Database Syst Rev       Date:  2019-10-21

3.  Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway.

Authors:  Prithwiraj De; Anita G Amin; Barbara Graham; Stacey L Martiniano; Silvia M Caceres; Katie R Poch; Marion C Jones; Milene T Saavedra; Kenneth C Malcolm; Jerry A Nick; Delphi Chatterjee
Journal:  J Cyst Fibros       Date:  2020-07-03       Impact factor: 5.482

4.  Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.

Authors:  Stephen D Lawn; Andrew D Kerkhoff; Rosie Burton; Charlotte Schutz; Andrew Boulle; Monica Vogt; Ankur Gupta-Wright; Mark P Nicol; Graeme Meintjes
Journal:  BMC Med       Date:  2017-03-21       Impact factor: 8.775

5.  Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.

Authors:  Helena Huerga; Gabriella Ferlazzo; Paolo Bevilacqua; Beatrice Kirubi; Elisa Ardizzoni; Stephen Wanjala; Joseph Sitienei; Maryline Bonnet
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

6.  Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.

Authors:  Tom H Boyles; Rulan Griesel; Annemie Stewart; Marc Mendelson; Gary Maartens
Journal:  Int J Infect Dis       Date:  2018-08-17       Impact factor: 3.623

7.  Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.

Authors:  Helena Huerga; Sekai Chenai Mathabire Rucker; Loide Cossa; Mathieu Bastard; Isabel Amoros; Ivan Manhiça; Kuzani Mbendera; Alex Telnov; Elisabeth Szumilin; Elisabeth Sanchez-Padilla; Lucas Molfino
Journal:  PLoS Med       Date:  2019-04-30       Impact factor: 11.069

8.  Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study.

Authors:  Tobias Broger; Bianca Sossen; Elloise du Toit; Andrew D Kerkhoff; Charlotte Schutz; Elena Ivanova Reipold; Amy Ward; David A Barr; Aurélien Macé; Andre Trollip; Rosie Burton; Stefano Ongarello; Abraham Pinter; Todd L Lowary; Catharina Boehme; Mark P Nicol; Graeme Meintjes; Claudia M Denkinger
Journal:  Lancet Infect Dis       Date:  2019-05-30       Impact factor: 25.071

9.  Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data.

Authors:  Tobias Broger; Mark P Nicol; Rita Székely; Stephanie Bjerrum; Bianca Sossen; Charlotte Schutz; Japheth A Opintan; Isik S Johansen; Satoshi Mitarai; Kinuyo Chikamatsu; Andrew D Kerkhoff; Aurélien Macé; Stefano Ongarello; Graeme Meintjes; Claudia M Denkinger; Samuel G Schumacher
Journal:  PLoS Med       Date:  2020-05-01       Impact factor: 11.069

Review 10.  Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications.

Authors:  Stephen D Lawn; Ankur Gupta-Wright
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-03       Impact factor: 2.184
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.